RISalud
Institutional Health Repository of Andalucía
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/556| Title: | Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer |
| Authors: | Menjón-Beltrán, S Olivencia-Dueso, R González-Jiménez, E Titos, MJ |
| metadata.dc.contributor.authoraffiliation: | [Menjón-Beltrán,S; Olivencia-Dueso,R; González-Jiménez,E; Titos,MJ] Unidad de Ginecología Oncológica, Hospital Universitario Virgen de las Nieves, Granada, Spain. |
| Keywords: | Anticuerpos Monoclonales Humanizados;Antineoplásicos;Neoplasias de la Mama;Metástasis de la Neoplasia;Antimetabolitos Antineoplásicos;Femenino;Humanos;Receptor erbB-2 |
| metadata.dc.subject.mesh: | Medical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms Medical Subject Headings::Diseases::Neoplasms::Neoplastic Processes::Neoplasm Metastasis Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Antimetabolites, Antineoplastic Medical Subject Headings::Check Tags::Female Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Phosphotransferases::Phosphotransferases (Alcohol Group Acceptor)::Protein Kinases::Protein-Tyrosine Kinases::Receptor Protein-Tyrosine Kinases::Receptor, erbB-2 |
| Issue Date: | 19-Jun-2007 |
| Publisher: | BioMed Central |
| Citation: | Menjón-Beltrán S, Olivencia-Dueso R, González-Jiménez E, Titos MJ .Study of the combination gemcitabine and trastuzumab in the treatment of HER2+ metastatic breast cancer. Breast Cancer Research 2007, 9(Suppl 1):P11 |
| Abstract: | Trastuzumab and gemcitabine are two active drugs for meta-static breast cancer (MBC) treatment. We conducted a retrospective study of this combination in patients with Her2+ MBC in our hospital. |
| Description: | Poster Presentation. This article is part of the supplement: VII Madrid Breast Cancer Conference: Changes in the treatment of breast cancer. |
| URI: | http://hdl.handle.net/10668/556 |
| metadata.dc.relation.publisherversion: | http://breast-cancer-research.com/content/9/S1/P11 |
| metadata.dc.identifier.doi: | 10.1186/bcr1717 |
| ISSN: | 1465-5411 (Print) 1465-542X (Online) |
| Appears in Collections: | 01- Artículos - Hospital Virgen de las Nieves |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Menjon_StudyOfThe.pdf | Poster presentation | 45,41 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License
